According to the National Rosacea Society, 16 million-plus Americans regularly deal with symptoms of rosacea. Flare-ups can feel like a nightmare: the patchy pink spots, the all-over facial redness, ...

Add Yahoo as a preferred source to see more of our stories on Google. Purvisha Patel, MD, is a board-certified dermatologist and founder of Advanced Dermatology & Skin Cancer Associates in Memphis and ...

Metronidazole-Based Standard of Care with Favorable Tolerability MIAMI BEACH, Fla., March 19, 2026 /PRNewswire/ -- Crescel LLC, an innovative science and technology company, today announced results ...

Please provide your email address to receive an email when new articles are posted on . More than 50% patients only try a rosacea treatment for 2 weeks despite the doctor-recommended 12 weeks.

Despite recent advances in rosacea therapy and an ongoing shift toward phenotype-driven treatment, experts told Medscape Medical News that addressing the multifaceted mechanisms of rosacea remains ...

Affecting up to 1 in 10 people worldwide, rosacea has a complex pathophysiology that remains inadequately understood, and research has hinted at multiple inflammatory and immune mediated processes ...

The medication can be taken with or without food, though ingestion of food along with Emrosi may help reduce the risk of esophageal irritation and ulceration. Emrosi ™ (minocycline hydrochloride ...

Do you feel like you’re always blushing or breaking out in pimples? You may have rosacea, a skin condition that affects more than 16 million Americans. Fortunately, doctors have tools to help. Other ...

Please provide your email address to receive an email when new articles are posted on . After three treatments, the effectiveness and excellent rates were 68.9% and 35.6%, respectively. Of the 16 ...

Journey Medical Corporation has announced the launch and initial distribution of Emrosi™, a new prescription medication designed to treat inflammatory lesions of rosacea in adults. Emrosi, which ...

FORT WORTH, Texas, Jan. 12 /PRNewswire/ -- Galderma Laboratories, L.P. today announced the availability of a new MetroGel(R) 1% Kit for the topical treatment of the inflammatory lesions of rosacea.

For people with chronic skin conditions, telehealth altered how they care for their skin and their bodies by removing ...